Keywords: مهار کننده های 5-آلفا ردوکتاز; Benign prostatic hyperplasia; 5-alpha reductase inhibitors; Lower urinary tract symptoms;
مقالات ISI مهار کننده های 5-آلفا ردوکتاز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های 5-آلفا ردوکتاز; Dementia; 5-Alpha reductase inhibitors; Finasteride; Dutasteride;
Keywords: مهار کننده های 5-آلفا ردوکتاز; prostate; prostate-specific antigen; 5-alpha reductase inhibitors; alopecia; dihydrotestosterone; 5aR; 5α-reductase; 5aRI; 5aR inhibitor; BPH; benign prostatic hyperplasia; PSA; prostate specific antigen;
Keywords: مهار کننده های 5-آلفا ردوکتاز; prostatic hyperplasia; diagnostic tests, routine; 5-alpha reductase inhibitors; standards; prostate-specific antigenAUA, American Urological Association; BPH, benign prostatic hyperplasia; EHR, electronic health record; LUTS, lower urinary tract symptoms;
Keywords: مهار کننده های 5-آلفا ردوکتاز; Drug adherence; Drug therapy; Benign prostatic hyperplasia; Lower urinary tract symptoms; Alpha blockers; 5-Alpha reductase inhibitors; Administrative database;
Keywords: مهار کننده های 5-آلفا ردوکتاز; prostate; prostatic hyperplasia; 5-alpha reductase inhibitors; finasteride; individualized medicine5AR, 5α-reductase; 5AR2, 5α-reductase type 2; 5ARI, 5α-reductase inhibitor; BPH, benign prostatic hyperplasia; DHT, dihydrotestosterone; GRP, gastrin releas
Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
Keywords: مهار کننده های 5-آلفا ردوکتاز; bladder neoplasms; 5-alpha reductase inhibitors; Finland; survival; adrenergic alpha-antagonists; 5-ARI; 5α-reductase inhibitor; BCa; bladder cancer; HILMO; Care Register for Health Care; SII; Social Insurance Institution of Finland; TURB; transurethral
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features
Keywords: مهار کننده های 5-آلفا ردوکتاز; prostatic neoplasms; watchful waiting; 5-alpha reductase inhibitors; neoplasm grading; risk factors; 5-ARI; 5α-reductase inhibitor; AS; active surveillance; DRE; digital rectal examination; PSA; prostate specific antigen; REDEEM; Reduction with Dutaster
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
Keywords: مهار کننده های 5-آلفا ردوکتاز; bladder neoplasms; neoplasm recurrence; local; androgen antagonists; prevention and control; 5-alpha reductase inhibitors; ADT; androgen deprivation therapy; AR; androgen receptor; AST; androgen suppression therapy; BCG; bacillus Calmette-Guérin; BPH; be
Effects of Withdrawing α1-Blocker from Combination Therapy with α1-Blocker and 5α-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective and Comparative Trial Using Urodynamics
Keywords: مهار کننده های 5-آلفا ردوکتاز; urinary bladder neck obstruction; lower urinary tract symptoms; adrenergic alpha-antagonists; 5-alpha reductase inhibitors; drug substitution; 5ARI; 5α-reductase inhibitor; α1-blocker; α1-adrenergic receptor blocker; BMI; body mass index; BOO; bladder
Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia
Keywords: مهار کننده های 5-آلفا ردوکتاز; prostatic hyperplasia; obesity; lower urinary tract symptoms; 5-alpha reductase inhibitors; epigenomics5AR, 5α-reductase; 5AR2, 5α-reductase type 2; 5ARI, 5α-reductase inhibitor; BMI, body mass index; BPH, benign prostatic hyperplasia; IHC, immunohistoche
The Association of Alpha-Blockers and 5-Alpha Reductase Inhibitors in Benign Prostatic Hyperplasia With Fractures
Keywords: مهار کننده های 5-آلفا ردوکتاز; Alpha-blockers; 5-Alpha reductase inhibitors; Fracture; Osteoporosis;
Clinical Progression, Acute Urinary Retention, Prostate-Related Surgeries, and Costs in Patients with Benign Prostatic Hyperplasia Taking Early Versus Delayed Combination 5α-Reductase Inhibitor Therapy and α-Blocker Therapy: A Retrospective Analysis
Keywords: مهار کننده های 5-آلفا ردوکتاز; alpha-blockers; 5-alpha reductase inhibitors; outcome assessment; prostatic hyperplasia;
Efficacy and safety of 120-W GreenLight High-Performance System laser photo vaporization of the prostate: 3-year results with specific considerations
Keywords: مهار کننده های 5-آلفا ردوکتاز; Lasers; Prostatic hyperplasia; Anticoagulants; 5-Alpha reductase inhibitors; Retention; Transurethral resection of prostate
Les médicaments de l'urètre
Keywords: مهار کننده های 5-آلفا ردوکتاز; Alpha-bloquant; Inhibiteur des 5-alpha réductases; Inhibiteur des phosphodiestérases 5; Extrait de plante; Toxine botulinique; Duloxétine hypertrophie bénigne de la prostate; Urètre; Incontinence urinaire; Alpha-blockers; 5-alpha reductase inhibitors
Dutasteride Reduces Prostatitis Symptoms Compared With Placebo in Men Enrolled in the REDUCE Study
Keywords: مهار کننده های 5-آلفا ردوکتاز; 5-alpha reductase inhibitors; dutasteride; prostatitis; 5ARI; 5α-reductase inhibitor; BPH; benign prostatic hyperplasia; CP; chronic prostatitis; CPCRN; Chronic Prostatitis Collaborative Research Network; CPPS; chronic pelvic pain syndrome; CPSI; Chronic
Dutasteride Reduces Prostate Size and Prostate Specific Antigen in Older Hypogonadal Men With Benign Prostatic Hyperplasia Undergoing Testosterone Replacement Therapy
Keywords: مهار کننده های 5-آلفا ردوکتاز; testosterone; prostate; 5-alpha reductase inhibitors; dihydrotestosterone5αRI, 5α-reductase inhibitor; BPH, benign prostatic hyperplasia; D, dutasteride; DHEA, dehydroepiandrosterone; DHT, dihydrotestosterone; FSH, follicle-stimulating hormone; I-PSS, Int